Professional Documents
Culture Documents
Chapter V Noncognitive Treatments of Memor 2019 Cognitive Rehabilitation o
Chapter V Noncognitive Treatments of Memor 2019 Cognitive Rehabilitation o
Chapter V Noncognitive Treatments of Memor 2019 Cognitive Rehabilitation o
Noncognitive Treatments
of Memory Impairments
not find any effect of tDCS to frontal and parietal brain regions for perfor-
mance in recognition memory and conclude that memory benefits of tDCS
are not easily replicated.
Manenti et al. (2012) reviewed three patient studies using tDCS. The
three studies concerned the treatment of Alzheimer’s disease patients using
anodal tDCS and all showed positive effects. One of the studies used
repeated sessions of anodal tDCS applied bilaterally over the temporal cor-
tex. Performance in a visual recognition test was used as the outcome var-
iable. Stimulation with tDCS increased memory performance in this group
and the effect was still observed at a follow-up session, 4 weeks after the end
of the stimulation. This result is interesting, but because of visual recognition
being a rather experimental outcome variable, the transfer to free recall and
everyday memory performance remains unclear. Moreover, the study did
not include a control group.
Bystad et al. (2016) conducted an RCT with tDCS applied over the left
temporal cortex in six 30-min sessions distributed over 10 days. Twenty-five
Alzheimer’s disease patients were included in the study: 12 received active
stimulation and 13 were given sham stimulation. Bystad et al. (2016) used
the California Verbal Learning Test (CVLT) as the outcome variable. They
found no significant change in the CVLT comparing the two groups, but the
increase in delayed recall approached significance (p ¼ 0.052). Compared to
the study reviewed by Manenti et al. (2012), Bystad et al. (2016) used fewer
tDCS sessions and included a very small sample of patients. This and focusing
on free recall instead of recognition may explain the differences between the
studies. Still, it seems to be fair to argue that evidence for using tDCS in Alz-
heimer’s patient to improve their memory performance is missing. How-
ever, there are several trials running on this topic, which will help to
clarify the prospect of tDCS in this patients group.
Two studies used tDCS to treat patients with memory impairments
resulting from a stroke. Yun, Chun, and Kim (2015) randomized 45 stroke
patients to three groups: one receiving anodal stimulation of the left anterior
temporal lobe, one receiving stimulation of the right anterior temporal lobe,
and one group receiving sham stimulation. Stimulation was delivered five
times a week for 30 min, for 3 weeks. The study was double-blinded, but
no information is available about concealment. Also, the definition of a pri-
mary outcome variable is somewhat vague, as the defined test (a verbal learn-
ing test) allowed for different evaluations (learning sum, delayed recall,
recognition, etc.). Inclusion criteria were experiencing a stroke within
the last 6 months, no lesion concerning the temporal lobes, and a score lower
Noncognitive Treatments of Memory Impairments 181
2. NEUROFEEDBACK
Neurofeedback has been used as a treatment of developmental disorders
such as attention deficit hyperactivity disorder (ADHD), but there are only
a few studies focusing on the prospect of this method in patients with mem-
ory deficits due to acquired brain damage. Recently, Renton, Tibbles, and
Topolovec-Vranic (2017) reviewed the application of neurofeedback in
182 Cognitive Rehabilitation of Memory